Container closure systems are part of biologic product quality, sterile-barrier assurance, and dose delivery. This guide connects CCIT, extractables and leachables, vial and prefilled-syringe risks, stability, shipping, in-use studies, and CTD Module 3.

A practical, end-to-end guide to mRNA-LNP CMC—from templates, IVT mRNA, lipid raw materials, and scale-up to potency, stability, comparability, and current global regulatory expectations.